Evidence map›Paper›PMID 25530887›Full record

ArticleAdvances in preventive medicine2014

Usage of EMBRACE(TM) in Gujarat, India: Survey of Paediatricians.

Somashekhar Nimbalkar, Harshil Patel, Ashish Dongara, Dipen V Patel, Satvik Bansal

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Advances in preventive medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06000826 (Efficacy of a Low-cost Warming Mattress Celsi Warmer for the Management of Hypothermic Newborns), which is not on this map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06000826 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Efficacy of a Low-cost Warming Mattress Celsi Warmer for the Management of Hypothermic Newborns

TypeinterventionalSponsorWilliam Marsh Rice UniversityRan2022 to 2024Enrolled90ConditionsNewborn HypothermiaArmsCelsi Warmer
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Kangaroo mother care: a systematic review of barriers and enablers.Bulletin of the World Health Organization · 2016
    Pooled it
  2. Embrace versus Cloth Wrap in preventing neonatal hypothermia during transport: a randomized trial.Journal of perinatology : official journal of the California Perinatal Association · 2021
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Somashekhar NimbalkarDepartment of Paediatrics, Pramukhswami Medical College, Anand, Karamsad, Gujarat 388325, India ; Central Research Services, Charutar Arogya Mandal, Anand, Karamsad, Gujarat 388325, India.
Harshil PatelDepartment of Paediatrics, Pramukhswami Medical College, Anand, Karamsad, Gujarat 388325, India.
Ashish DongaraDepartment of Paediatrics, Pramukhswami Medical College, Anand, Karamsad, Gujarat 388325, India.
Dipen V PatelDepartment of Paediatrics, Pramukhswami Medical College, Anand, Karamsad, Gujarat 388325, India.
Satvik BansalDepartment of Paediatrics, Pramukhswami Medical College, Anand, Karamsad, Gujarat 388325, India.
Pramukhswami Medical College · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim. EMBRACE(TM) is an innovative, low cost infant warmer for use in neonates. It contains phase change material, which stays at constant temperature for 6 hours. We surveyed paediatricians using EMBRACE(TM) regarding benefits, risks, and setup in which it was used in Gujarat. Methods. Questionnaire was administered telephonically to 52 out of 53 paediatricians. Results. EMBRACE(TM) was used for an average of 8.27 (range of 3-18, SD = 3.84) months by paediatricians. All used it for thermoregulation during transfers, for average (SD) duration of 42 (0.64) m per transfer, 62.7% used it at mother's side for average (SD) 11.06 (7.89) h per day, and 3.9% prescribed it at home. It was used in low birth weight neonates only by 56.9% while 43.1% used it for all neonates. While hyperthermia was not reported, 5.9% felt that EMBRACE(TM) did not prevent hypothermia. About 54.9% felt that they could not monitor the newborn during EMBRACE(TM) use. Of paediatricians who practiced kangaroo mother care (KMC), 7.7% have limited/stopped/decreased the practice of KMC and substituted it with EMBRACE(TM). Conclusions. EMBRACE(TM) was acceptable to most but concerns related to monitoring neonates and disinfection remained. Most paediatricians felt that it did not hamper KMC practice.

Identifiers

PMID25530887
PMCPMC4230002
OpenAlexW2054535823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.